Alamar Biosciences, Inc. planned insider sales
In the last twelve months insiders at Alamar Biosciences, Inc. filed 4 Form 144 notices of planned sales, 2.4 million shares worth $56.4 million at the time of filing, from 4 sellers. The latest, filed 14 October 2026: Qiming Managing Directors Fund VI, L.P. (affiliate), 41,945 shares worth $987,000, planned for around 14 October 2026 through J.P. Morgan Securities LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 14 October 2026 | Qiming Managing Directors Fund VI, L.P. | Affiliate | 41,945 | $987,000 | 14 October 2026 | None on Form 4 yet | J.P. Morgan Securities LLC | Private investment in Series A-3 preferred shares, automatically converted into common stock upon IPO; Private investment in Series A-4 preferred shares, automatically converted into common stock upon IPO; Private investment in Series B preferred, automatically converted into common stock upon IPO | Form 144 |
| 14 October 2026 | Qiming Venture Partners VIII Investments, LLC | Affiliate | 363,729 | $8.6 million | 14 October 2026 | None on Form 4 yet | J.P. Morgan Securities LLC | Private investment in Series C preferred shares, automatically converted into common stock upon IPO | Form 144 |
| 14 October 2026 | Qiming Venture Partners VIII-HC, L.P. | Affiliate | 435,468 | $10.2 million | 14 October 2026 | None on Form 4 yet | J.P. Morgan Securities LLC | Private investment in series C preferred shares; automatically converted into common stock upon IPO | Form 144 |
| 14 October 2026 | Qiming Venture Partners VI, L.P. | Affiliate | 1,558,858 | $36.7 million | 14 October 2026 | 1,200,000 shares from 15 October 2026 | J.P. Morgan Securities LLC | Private investment in Series A-3 preferred shares, automatically converted into common stock upon IPO; Private investment in Series A-4 preferred shares, automatically converted into common stock upon IPO; Private investment in Series B preferred, automatically converted into common stock upon IPO | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.